Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-01

Clinical Trial Update: Thalidomide in Treating Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating thalidomide for Crohn's disease has completed according to the update. No efficacy results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalomid (thalidomide)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED